chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the Moderna Bivalent COVID-19 booster on 10/21/2022. On 1/5/2023, I woke up not feeling well. I had a dull headache and a sore throat. As the day progressed, they grew more intense, but I didn't develop any other symptoms. I took my BP and my temperature, both of which were within the normal range. I also had a little bit of malaise and fatigue. I took a home antigen test that day and got a positive result. I had a video chat with a PA at the clinic I go to, and I was prescribed PAXLOVID, which I began taking that evening. I was also instructed to stop taking my rosuvastatin while I was on PAXLOVID on account of a negative interaction between the two. On 1/6/2023, I continued to have a sore throat, headache, and a little bit of tiredness. On 1/7/2023. my headache was fading, though I still had a sore throat. My BP also shot up, and I had to go to the ER. At the ER, when they took my BP, it registered at 204/98. They conducted blood work, a chest X-ray, and an EKG. After I was at the ER for a couple of hours, my BP had decreased to about 157/85. They didn't give me any treatment or medication, and they advised me to see my PCP. I saw my PCP on 1/12/2023. When I was at the PCP's office, my BP was tolerable, but it was still a bit higher than ideal. My PCP referred me to a cardiologist, whom I am scheduled to see at the end of this month. After I began taking the PAXLOVID, my symptoms steadily began to fade, and by the time I saw my PCP on 1/12/2023, my symptoms were pretty much gone. I took a home antigen test on 1/17/2023 and got a negative result. Even though I had a negative result, though, I had a runny nose and sneezing, which lasted from 1/17/2023 until 1/21/2023. I don't know if I had a cold or RSV at that point. I took CORICIDIN HBP to treat it, and it was effective.
Initial report was received from a health care professional on 25 October 2011. A female patient had received FLUZONE (lot number, route, site and date of administration not reported) and within two hours of immunization, experienced a migraine and severe muscle aches. Within four hours the patient developed nausea, vomiting, a temperature of 103, shortness of breath and an itchy rash on trunk. The patient reported that she does not use contact solution with timerosol (thimerosal) as she has an allergy to it. No further information was available at the time of the report. The patient's outcome was not reported. The reporter for this case is the same as for case 2011-10407. Documents held by sender: none.
Patient signed consent form that he has not received a previous dose of COVID-19 vaccine. Upon entering the information later this evening, I noticed he received a Pfizer series in March/April 2021 elsewhere. His insurance was billed today for the Janssen and there was no flag that he had received prior doses.
This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (headaches similar to Migraines) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.On 13-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (headaches similar to Migraines). At the time of the report, MIGRAINE (headaches similar to Migraines) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Treatment information was provided.No Concomitant medication was provided.
NAUSEA/COULDNT EAT ANYTHING; HEADACHES; This spontaneous report received from a patient concerned a 71 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included restless leg syndrome, alcohol user, and non-smoker, and other pre-existing medical conditions included the patient is not a drug abuse or illicit drug user. antiemetics flares up restless leg syndrome. The patient experienced drug allergy when treated with diphenhydramine hydrochloride. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 17-MAY-2021 for prophylactic vaccination. Concomitant medications included tramadol for restless leg syndrome. On 20-MAY-2021, the subject experienced nausea/couldnt eat anything. On 20-MAY-2021, the subject experienced headaches. Treatment medications (dates unspecified) included: bismuth subsalicylate, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nausea/couldnt eat anything, and had not recovered from headaches. This report was non-serious.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of an unknown gender and age. The patients' concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored ZOSTAVAX lot#L000448 and expiration date: 08-MAR-2016 (dose and route of administration were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
The day following vaccine pt - had swelling and redness @ injection site with itching. Saw MD. ? cellulitis - no tx other than cold/hot packs, resolved without complications.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction reported. On unknown dates the patients were vaccinated with doses of improperly stored PNEUMOVAX 23 (dose and route were unknown) lot # K004483 with expiration date 26-FEB-2016. No concomitant therapy was provided. No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
The same afternoon about 7pm my arm started to swell, it moved to arm and wrist. I couldn't sleep. It lasted about 5 hours. I had fever and chills that had subsided by morning. I still had arm pain and my blood pressure was trough the roof. I went to see the doctor the next day. The doctor did not not see anything concerning.
Fatigue lasting 5 days  Rash, itching, swelling, hot at injection spot on day  8
Patient has Cellulitis to left arm, at site of reported COVID vaccine, vaccine was administered at the Health Department, I do not have record to review at this time to confirm lot number of vaccine. Patient was prescribed Keflex, unsure of outcome as visit occurred today and patient has yet to start treatment.
seizure; This case was reported by a other health professional via sales rep and described the occurrence of seizure in an unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the seizure was unknown.   It was unknown if the reporter considered the seizure to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The medical assistant reported that a physician in another office informed the physician at her office that they had experienced cases of seizure after the administration of Bexsero. The other physician at her office was switching to Trumenba because the physician at her office trusts the physician who reported the cases of seizures.  The reporter did not consent to follow up.
Red/inflamed area around injection site but not immediately where shot given. Started day after injection (9-29-11) when returned to pharmacy looked almost like scab - dark red, scaly in appearance.
Reaction to Booster. Within 3-4 hours: Headache, nausea, severe body aches (especially in back). >100 F fever off and on for the next 3 days. Morning after booster, woke with significant angioedema of lips and left eye.
I was perfectly fine when I went to get vaccinated and I was okay until the third day (Monday April 16th 2021) I had a fever of 103 lasting for 4 days, I had to go to the emergency room because my fever was not breaking I was sweating and had the chills. Now I was reported to have a kidney infection and I was again perfectly fine before I went to take the test. Also were the injection site on my arm it had a knot for three days and it went down and the symptoms started. That was ONLY MY first dose and now I?m scared to get the second because of what I just went through.
Cellulitis, redness, put on ORAPRED and cefadroxil.
pt recv vax & devel hives; MD later determined that the pt had devel scabies, not hives; No further info was provided;
Throat itching; This is a spontaneous report from a contactable consumer (parent). A 17-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE, Solution for injection, Lot number: ER8733) via unknown route of administration on 17Jun2021 as dose 2 single for COVID-19 immunization. Medical history and Concomitant medications were not reported. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE) on 27May2021 for COVID-19 Immunization and had no reaction. Patient went to get her second shot yesterday but today she was saying her throat was itching on 18Jun2021. No treatment for adverse event. The outcome of event was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Patient admitted for confusion, dizziness, fatigue, substernal chest pain, cough, SOB, generalized abdominal pain with worsening symptoms.  Treatment includes: Lovenox, Dexamethasone, Albuterol, and Remdesivir.
Within 2 hours of receiving my second Covid 19 vaccine I developed fever, chills, nausea, vomiting, myalgias, arthralgias which persisted for 36 hours.  After 36 hours, the acute symptoms improved, but  I have had persistent daily fever, sweats, chills.  The fever has been  as high as 102 degrees F orally.  The night sweats have been extremely drenching.  I also have had ongoing fatigue and have been unable to work or perform my usual activities.
Patient was given 2nd dose of Moderna COVID vaccine at 3:51p 4/28/21. Pt waited the 15 minutes symptom free and was released (Had no reaction other than common flu like symptoms with first dose) Pt returned around 5:00p complaining of mild itching around arms and a little on face. I inspected injection site, and there was no redness or hives at injection site, or along arms and face. Pt reported hx of allergic reaction to Mangos and experience treating. Pt is assistant manager here at this store, and as such, we agreed that she could take benadryl and watch and wait. At 5:30 and then again at 6:00p she reported taking 25mg benadryl, then at around 6:05 she reported to the window with difficulty swallowing. At this, we activated the emergency response and I instructed to call 911 and called a Code White, for which a staff member was already on hand. At 6:12p we administered 0.3mg Epinephrine auto-injector 00115-1694-49. Shortly after they became nauseous and requested a waste bin. We gave the pt a cool damp compress for the back of her neck and the EMS arrived at ~6:17p. She remained moderately nauseous as the loaded her on the cart, though there was never any emesis. I then related the events and dosage times to the EMT as her partner helped move the pt onto the cart and then they left with the pt. Spoke with staff member and she said she was going to call EOC and that I should call our MHWD which I did.
Patient passed out immediately after receiving and fell forward onto floor.   She very quickly came to and was able to sit up.  She was given water, cookies and oj and observed for 20-30 minutes.   She stated she felt better and admitted to not haven eaten anything all day.
Erythema, pain, warmth at injection site 6 inches long 4 inches wide.
Patient had an allergic reaction after administration. Patient received diphenhydramine and prednisone.
This is a spontaneous report from a Pfizer-sponsored program via a contactable female consumer (Patient reported for herself). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, batch/lot number was not reported) via an unspecified route of administration on an unspecified date as first dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that she was going to receive the second dose of the Pfizer COVID vaccine on Feb 18, 2021. She was scheduled for carpel tunnel surgery on Feb 23, 2021. The pain medication that she was going to use is nonsteroidal like an ibuprofen. She did not want to blunt the Pfizer COVID vaccine response, so she will gladly delay the surgery, if Pfizer thinks it was more appropriate. She asked if she could take the nonsteroidal pain medication that soon after the second dose of the Pfizer COVID vaccine or should she delay the surgery? She stated she can delay it if needed. Clarification of which nonsteroidal product she was to use not provided. The patient was unwilling to complete report. The outcome of the event was reported as unknown. Information on the lot/batch number has been requested. Follow-up attempts have been completed and no further information is expected.
At 5 minutes post vaccination client C/O feeling nauseous and dizzy. Skin pale and diaphoretic. Assisted to supine position with legs elevated. BP 90/40  HR 56  RR 18, A&O x4, no other signs or symptoms. Client stated she had the same reactions when donating blood and had to stop for that reason. 911 notified. At 15 minutes post vaccination client stated feeling better BP 120/70 HR 70  RR 18.  EMS on scene. Client refused transport or follow up in ER with symptom resolution at 12:50.  No symptoms consistent with anaphylaxis were observed or reported.
Pt developed cellulitis and severe myositis and abscess of L upper arm requiring IV abx for 2 weeks plus.  He also developed a Hepatitis seconadry to serum sickness vs reaction to staph toxins from infection.
Spongiotic Dermatitis, all over entire body.Biopsy was taken to confirm. Condition present at this time for 2 weeks and still persists. Topical ointment  daily treatments X2. Redness and raised welts so far for 2 weeks.
Patient called stating she has had severe joint pain in the arm she received her flu vaccine in. She states it's lasted for several weeks.
8/4-Client in a.m. red swollen and warm to touch, 2 inches below original injection. Feels better today client states. There is only a bruise at deltoid muscle-never has been redden or swollen at injection area.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/06/21 2nd dose01/27/21 Diagnosed covid positive:09/14/21 Symptom onset:09/11/21 Exposure:Home Symptoms:HA,NAUSEA,DIARRHEA
Pt stated she noticed her glands in her neck are swollen and it hurts to swallow.  She is very tired today.  She had no reactions to the vaccine last year.  She also stated it was difficult to swallow because very dry mouth/pasty.
Pt stated that she was having some redness & swelling at injection site. Provider looked at site & no redness noted.
After receiving flu vaccine, patient reported back to clinic complaining of severe itching and "hoarseness" in voice. Was given 50 mg PO BENADRYL and sent immediately to emergency dept. Received epinephrine and prednisone in ER.
Client was administered Hep A in right deltoid and menactra right lateral arm and PPD implant  right forearm at around 4:55pm.Erythema and few papules immediately below site of injection and a macular rash on left forearm.Client claims it was itchy.Benadryl Elixir 2 tsp was given at 5pm.Advised to stay for 20 mins to observe.
My husband died on Feb 5. 2021.  I do not know if the vaccination had any effect but he died of heart attack from Coronary Artery Disease which was unknown.
Severe chills for 2 days, nausea, headache now for 3 days and still going strong.
Rash approx 4" in diameter at injection site.  Area is swollen, red and itches.
Pt c/o chills, body aches, injection site pain, and headache 1 day after vaccine administration. Seen in clinic the following day- symptoms have resolved.
By 10am on the 19th, my arm hurt, and my arm mobility was impaired.  By 1:30pm, I was feeling increasingly tired and had a low fever.  By 8pm, I was shivering, weak, and sensitive.  By 10pm, my nose got really dry.  On the 20th, I still had all of these symptoms.  On the 21st, I had all of these symptoms, plus I got a pain behind my eyes.  Each day after that, I had all of the symptoms, but they continued to get milder each day until I finally felt almost all better on the 24th.
patient passed  83 days without receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient passed  83 days without receiving the second dose) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient passed  83 days without receiving the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient passed  83 days without receiving the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant and  treatment medications were provided.
consumer reports that pt was immunized 1NOV92 & became sick & could hardly breathe; treated w/ATB since November & @ time of this report, still has difficulty breathing;
3/29-YESTERDAY MORNING, WOKE UP ARM WAS RED, SWOLLEN, WARM TO THE TOUCH, BRUISED WITH PAIN, NUMB TODAY.
terrible headache; Nausea; Body aches; lymph node is bothersome; Stated that she had the vaccine on Sunday and had Covid all over again on Monday.; Fever of 101; Chills; This is a spontaneous report from a contactable consumer (patient). This 68-year-old female patient received dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 07Mar2021 (at the age of 68-years-old) as a single dose for COVID-19 immunization. Medical history included COVID-19 in Oct2020 for which she was not hospitalized but pretty sick. Concomitant medications were not reported. On Sunday (07Mar2021), the patient experienced ran a 101 fever and chills. The patient "had COVID-19 all over again" on Monday (08Mar2021). She had no sore throat or lymph node problems. Today (10Mar2021) the patient woke up at 03:00 with chills, terrible headache, nausea, body aches, and lymph node bothersome. The patient wanted to know if with the second dose she could expect similar. The outcomes of fever, chills, COVID-19, headache, nausea, body aches, and lymph node bothersome were unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
The correct vaccine was administered but it was expired by 15 hours and 34 minutes. It was opened 05/24/23 at 12:00 pm.
I had the normal arm soreness and fatigue for a few days. I received my flu vaccine one week prior to my Covid Booster. A couple of weeks after my booster I noticed that I was starting to have significant hair loss and I am continuing to have significant hair loss at the 3 month mark.
1. History of palpitations but recent increase in frequency.  No associated symptoms.  She has had some recent stress and anxiety over surgery decision and this could be related.  Will update basic labs first and determine if further testing needs to be done. 2. Localized reaction has now resolved.  Advised to continue with second vaccination.
Red maculopapules x 3 clustered on left upper anterior thigh at site of VCZ vaccine.
Pt's left arm was sore and with a walnut-sized lump X 10-13 days and disappeared. Pt had a rash on body, sores in mouth, joint and muscle pain. She was seen at Urgent Care X 2 then saw a dermatologist X 3 months. Vasculitis due to influenza was medical Dx. Pt's left and right ankles were tender, scarred and stinging. Buspar was taken.
Admitted 2/21 for fall at NH, tested COVID+,  PNA. Vaccine 1/4, 1/29. Dtr also states pt was COVID + initially 1/18/21. Treated w/zinc and vitamins. DCd back to NH.
Initial report received on 26 June 2008 from a nurse.  A 21-year-old female patient, with no concurrent illnesses or pre-existing medical conditions, had received a first intramuscular left deltoid injection of MENACTRA (Lot # U2632AA) on 24 June 2008 at 11:00 am.  Approximately four hours post-vaccination around 15:00 pm, the patient experienced pain the left deltoid injection site with tingling of her left arm down to her fingers.  Her fingers were cool, but her radial pulse was strong.  She also complained of nausea.  The patient was treated with oral Tylenol and was to be seen for follow-up with the nurse practitioner.  No relevant diagnostic tests or laboratory data were performed.  The recovery status of the patient was not reported. Follow-up information was received in August 2008 from a health care professional. The reporter verified that upon follow-up evaluation by the nurse practioner, the patient had received. The patient had not received a neurology consult and addtional imformation was not required. The final diagnosis had been "vaccine reaction vs. viral:. The patient recovered fromt he event on 23 June 2008.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), RASH (rash), PRURITUS (itchy) and ERYTHEMA (red) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No medical history was provided by the reporter.  On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced PAIN (pain), RASH (rash), PRURITUS (itchy) and ERYTHEMA (red). At the time of the report, PAIN (pain), RASH (rash), PRURITUS (itchy) and ERYTHEMA (red) outcome was unknown.
This spontaneous report as received from a Licensed Practical Nurse refers to unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history was not provided. On unknown dates, the patients were vaccinated with improperly stored LIQUID PEDVAXHIB (unknown strength and route) lot # K004541 and expiry date of 04-DEC-2016 or lot # K015463 and expiry date of 09-JUL-2017. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.